Cargando…
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
As the USA faces a worsening overdose crisis, improving access to evidence-based treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory changes in response to the COVID-19 pandemic substantially expanded flexibilities on take-home doses for methadone treatment for OUD....
Autores principales: | Krawczyk, Noa, Rivera, Bianca D, Levin, Emily, Dooling, Bridget C E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949855/ https://www.ncbi.nlm.nih.gov/pubmed/36841564 http://dx.doi.org/10.1016/S2468-2667(23)00023-3 |
Ejemplares similares
-
Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.
por: Krawczyk, Noa, et al.
Publicado: (2023) -
Economic Implications of Potential Changes to Regulatory and Reimbursement Policies for Medical Devices
por: Reed, Shelby D., et al.
Publicado: (2007) -
Pandemic Action Plan Policy and Regulatory Summary Telehealth Policy and Regulatory Considerations During a Pandemic
por: VanderWerf, Mark, et al.
Publicado: (2022) -
Exploring perceptions and experiences of patients who have chronic pain as state prescription opioid policies change: a qualitative study in Indiana
por: Al Achkar, Morhaf, et al.
Publicado: (2017) -
Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength
por: Haber, Noah A, et al.
Publicado: (2022)